scholarly journals Evaluation of the Role of Digital Rectal Examination and Transrectal Ultrasonography in Diagnosis of Prostate Cancer in Turkish Men

2012 ◽  
Vol 3 (2) ◽  
Author(s):  
Cavit Ceylan
1995 ◽  
Vol 81 (4) ◽  
pp. 225-229 ◽  
Author(s):  
Stefano Ciatto ◽  
Rita Bonardi ◽  
Antonia Mazzotta ◽  
Claudio Lombardi ◽  
Roberto Santoni ◽  
...  

Aims and background To evaluate the performance and feasibility of screening for prostate cancer by comparing screening modalities. Methods Prospective study of two comparable cohorts of healthy resident males aged 60 to 75 years. Screening attenders in the two invited cohorts were screened either by digital rectal examination (DRE) and transrectal ultrasonography (TRUS), or by serum prostate-specific antigen determination (PSA: cutoff 4 ng/ml). Attendance and biopsy rates, predictive values, prevalence of screen-detected cancers, as well as screening costs were determined, and the efficiency of the two screening modalities was compared. Results 1425 subjects were screened by DRE + TRUS. Attendance rate was 33.7%, the biopsy rate was 2.7%, and the prevalence of detected cancers was 1.82%. A total of 1315 subjects was screened by PSA. Attendance rate was 66.9%, the biopsy rate was 2.8%, and the prevalence of detected cancers was 1.67%. Screen-detected cancer stage was more favorable than observed in clinical practice, and early detection was evident, with the prevalence/incidence ratio higher than 10:1 in both programs. The cost per subject screened was about 34,000 Lire for DRE + TRSU and about 30,000 Lire for PSA program. Conclusions The study confirms that early detection of prostate cancer is possible and that screening is practically feasible. Both screening modalities achieved comparable results as regards early detection, but screening by PSA had a higher compliance and lower costs. PSA seems the ideal test to be used in prospective controlled studies aimed at demonstrating screening efficacy.


1994 ◽  
Vol 152 (5 Part 1) ◽  
pp. 1506-1509 ◽  
Author(s):  
Robert C. Flanigan ◽  
William J. Catalona ◽  
Jerome P. Richie ◽  
Frederick R. Ahmann ◽  
M’Liss A. Hudson ◽  
...  

2006 ◽  
Vol 98 (5) ◽  
pp. 982-985 ◽  
Author(s):  
Chao-Yu Hsu ◽  
Steven Joniau ◽  
Raymond Oyen ◽  
Tania Roskams ◽  
Hein Van Poppel

2015 ◽  
Vol 21 (1) ◽  
pp. 111 ◽  
Author(s):  
Jane Crowe ◽  
Addie C. Wootten ◽  
Nicholas Howard

The role of the General Practitioner (GP) in testing for and managing men with prostate cancer (PCa) is significant. Very few studies have explored the attitudes and practices of Australian GPs in the context of the role of PCa testing. In this study, a 46-item web-based questionnaire was used to assess self-reported PCa testing attitudes and practices of GPs. This questionnaire was circulated to divisions of general practice and Medicare locals for further distribution to their GP members across Australia. GPs from all states and territories participated, and a total of 136 GPs completed the survey. Of the responding GPs, 57% always or usually offered PCa testing to asymptomatic men ≤70 years of age and 60% of GPs always or usually included a digital rectal examination (DRE). Many (80%) of the GPs stated that the current PCa testing guidelines were not clear. PCa testing was offered opportunistically by 56% while 39% offered testing at the patient’s request. The results captured in this study represent a snapshot of GP attitudes and practices from across Australia. The results presented indicate a wide variation in the approaches to PCa testing in general practice across Australia, which in most part appear to be related to the lack of clarity of the current prostate cancer testing guidelines.


2008 ◽  
Vol 54 (3) ◽  
pp. 581-588 ◽  
Author(s):  
Claartje Gosselaar ◽  
Monique J. Roobol ◽  
Stijn Roemeling ◽  
Fritz H. Schröder

Sign in / Sign up

Export Citation Format

Share Document